Replies to post #385480 on Amarin Corp Plc (AMRN)

[Whalatane]

Interesting post … thx
If MITIGATE reduces Covid caused hospitalization / serious events … or as Dr Bhatt theorized … is a “ tipping pt “ for CV events … then I expect Kaiser will prescribe all their patients that match the trials inclusion criteria …on V by the end of this year .

As per trial design
Trial was fully enrolled on Sept 1st 2021
They will have 12 mth data on all … Sept 2 2022
If Kaisers EHR ( in house electronic recording system ) is as good as they claim it is …. they will know roughly within a week if V worked

After rechecking data etc they should have top line data with a month and detailed data for AHA in Nov .

This data is all “ in house “ and in Nth Ca

Kiwi

[Whalatane]

retina I agree that positive MITIGATE results will be a big deal for AMRN .

My guess is that most are ignoring the trial or expect little risk reduction

Kiwi